@RaceOncology reading these comments above about possible outcomes for bisantrene & RAC, do you or the board have a longer term vision for the company, ie post bisantrene being validated as CPAC, that you can articulate
For example, would you like to see
- bis being sold off completely
- bis being licenced providing substantional annuity income to fund other endeavours
- RAC becoming a molecule development company (noting the 39 unique FTO protein-binding molecules recently discovered)
- RAC being sold off lock, stock & barrel
- any combination of the above
- somehting else
Interested in your thoughts......
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.025(2.08%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.17 | $130.6K | 109.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10250 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 2000 | 1 |
View Market Depth
| Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |